PFIZER INC Increase (Decrease) in Accounts Payable
PFIZER INC (PFE) reported Increase (Decrease) in Accounts Payable of $297.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2015-02-27
- PFIZER INC increase (decrease) in accounts payable for fiscal 2014 was $297.00M, a 22.25% decline from fiscal 2013.
- PFIZER INC increase (decrease) in accounts payable for fiscal 2013 was $382.00M, a 34.02% decline from fiscal 2012.
- PFIZER INC increase (decrease) in accounts payable for fiscal 2012 was $579.00M.
- PFIZER INC increase (decrease) in accounts payable for fiscal 2011 was -$367.00M.
| Period end | Increase (Decrease) in Accounts Payable 12 month |
|---|---|
| 2014-12-31 | $297.00M 10-K · filed 2015-02-27 |
| 2013-12-31 | $382.00M 10-K · filed 2015-02-27 |
| 2012-12-31 | $579.00M 10-K · filed 2015-02-27 |
| 2011-12-31 | -$367.00M 10-K · filed 2014-02-28 |
| 2010-12-31 | -$301.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |